Akihiro Hori

Title: Akihiro Hori: Innovator in Medicinal Chemistry

Introduction

Akihiro Hori is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating diseases associated with amyloid-β proteins. With a total of 12 patents to his name, Hori's work is recognized for its potential impact on healthcare.

Latest Patents

Among his latest patents, Hori has developed oxazine derivatives that serve as medicaments for treating or preventing diseases induced by the production, secretion, or deposition of amyloid-β proteins. One notable compound is defined by a specific formula, which includes various substituents and their pharmaceutically acceptable salts or solvates. Additionally, he has created sulfur-containing heterocyclic derivatives that exhibit beta-secretase inhibitory activity, providing further options for treating diseases linked to amyloid-β protein.

Career Highlights

Hori has worked with notable companies, including Shionogi & Company Limited, where he has contributed to innovative research and development projects. His expertise in medicinal chemistry has positioned him as a key figure in the industry, driving advancements in therapeutic solutions.

Collaborations

Throughout his career, Hori has collaborated with esteemed colleagues such as Naotake Kobayashi and Kazuo Ueda. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Akihiro Hori's contributions to medicinal chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in treatments for diseases related to amyloid-β proteins.